This Liver Oriented Continuing Medical Education activity provides a forum for Gastroenterologists, Hepatologists, Hepatobiliary surgeons, as well as primary care physicians, physician assistants, nurse practitioners, nurses, and other health care professionals who deal with patients with Chronic Liver Disease to gather and discuss the latest diagnostic and management strategies in these patients.
The advent of newer therapies for Hepatitis B and C have revolutionized the care of these patients and the optimum protocols for naïve and refractory patients will be outlined, including a view to those marginalized patients. Likewise the diagnosis and treatment of NAFLD and Autoimmune liver disease has advanced and this will be comprehensively covered.
Finally, Cirrhotic stage liver disease and its sequelae: Decompensation and Hepatocellular Carcinoma, will clearly be discussed to allow the practitioner to efficiently diagnose and treat these eventualities as well as know when to refer a patient for collaborative therapy including HCC care and Transplantation.
The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Rochester School of Medicine and Dentistry designates this live activity for a maximum of 5.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Saturday, September 29, 2018 at 8:00am to 2:30pm
School of Medicine and Dentistry, Flaum Atrium & Class of '62 Auditorium
415 Elmwood Ave, Rochester, NY 14642